Quantitative analysis of SOD2, ALDH1A1 and MGST1 messenger ribonucleic acid in anterior lens epithelium of patients with pseudoexfoliation syndrome

Molecular Vision

Volumn 19, Issue , 2013, Pages 1341-1349

  Strzalka Mrozik, Barbara ^a   Prudlo, Lilianna ^a   Kimsa, Malgorzata W ^a   Kimsa, Magdalena C ^a   Kapral, Malgorzata ^a   Nita, Malgorzata ^a   Mazurek, Urszula ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; GLUTATHIONE TRANSFERASE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; MICROSOMAL GLUTATHIONE S TRANSFERASE 1; MOLECULAR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ALDH1A1 GENE; ANTERIOR LENS CAPSULE; AREA UNDER THE CURVE; ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; FEMALE; GAPDH GENE; GENE; GENE ACTIVITY; GENE EXPRESSION PROFILING; GENE FUNCTION; GENOMIC FRAGMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MGST1 GENE; OXIDATIVE STRESS; PRIORITY JOURNAL; PSEUDOEXFOLIATION; QUANTITATIVE ANALYSIS; RANK SUM TEST; SENSITIVITY AND SPECIFICITY; SOD2 GENE;

AGED; AGED, 80 AND OVER; ALDEHYDE DEHYDROGENASE; ANTERIOR CAPSULE OF THE LENS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EPITHELIUM; EXFOLIATION SYNDROME; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; SUPEROXIDE DISMUTASE;

EID: 84878998158     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Schlötzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol 2006; 141:921-37. [PMID: 16678509].
2. Ritch R. Exfoliation syndrome. Curr Opin Ophthalmol 2001; 12:124-130. [PMID: 11224719].
3. Schlötzer-Schrehardt U. Genetics and genomics of pseudoexfoliation syndrome/glaucoma. Middle East Afr J Ophthalmol 2011; 18:30-36. [PMID: 21572731].
4. Schlötzer-Schrehardt UM, Koca MR, Naumann GO, Volkholz H. Pseudoexfoliation syndrome. Ocular manifestation of a systemic disorder? Arch Ophthalmol 1992; 110:1752-1756. [PMID: 1463418].
5. Streeten BW, Li ZY, Wallace RN, Eagle RC Jr, Keshgegian AA. Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome. Arch Ophthalmol 1992; 110:1757-1762. [PMID: 1463419].
6. Schlötzer-Schrehardt U. Molecular pathology of pseudoexfoliation syndrome/glaucoma-new insights from LOXL1gene associations. Exp Eye Res 2009; 88:776-785.[PMID: 18809397].
7. Comhair SA, Erzurum SC. Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal 2010; 12:93-124. [PMID: 19634987].
8. Vasiliou V, Nebert DW. Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2005; 2:138-143. [PMID: 16004729].
9. Yildirim Z, Ucgun NI, Yildirim F. The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration. Clinics (Sao Paulo) 2011; 66:743-746. [PMID: 21789374].
10. Manda G, Nechifor MT, Neagu TM. Reactive Oxygen Species, Cancer and Anti-Cancer Therapies. Curr Chem Biol 2009; 3:22-46.
11. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2007; 2:219-236. [PMID: 18044138].
12. Cabrera MP, Chihuailaf RH. Antioxidants and the integrity of ocular tissues. Vet Med Int 2011; 2011:905153- [PMID: 21789267].
13. Chen Y, Mehta G, Vasiliou V. Antioxidant defenses in the ocular surface. Ocul Surf 2009; 7:176-185. [PMID: 19948101].
14. Lobo V, Patil A, Phatak A, Chandra N. Free radicals, antioxidants and functional foods: Impact on human health. Pharmacogn Rev 2010; 4:118-126. [PMID: 22228951].
15. Sies H. Total antioxidant capacity: appraisal of a concept. J Nutr 2007; 137:1493-1495. [PMID: 17513413].
16. Spector A. Review: Oxidative stress and disease. J Ocul Pharmacol Ther 2000; 16:193-201. [PMID: 10803430].
17. Lou MF. Redox regulation in the lens. Prog Retin Eye Res 2003; 22:657-682. [PMID: 12892645].
18. Zenkel M, Pöschl E, von der Mark K, Hofmann-Rummelt C, Naumann GO, Kruse FE, Schlötzer-Schrehardt U. Differential gene expression in pseudoexfoliation syndrome. Invest Ophthalmol Vis Sci 2005; 46:3742-3752. [PMID: 16186358].
19. Strzalka-Mrozik B, Stanik-Walentek A, Kapral M, Kowalczyk M, Adamska J, Gola J, Mazurek U. Differential expression of transforming growth factor-β isoforms in bullous keratopathy corneas. Mol Vis 2010; 16:161-166. [PMID: 20142847].
20. Gottipati S, Cammarata PR. Mitochondrial superoxide dismutase activation with 17 beta-estradiol-treated human lens epithelial cells. Mol Vis 2008; 14:898-905. [PMID: 18490963].
21. Nezzar H, Chiambaretta F, Marceau G, Blanchon L, Faye B, Dechelotte P, Rigal D, Sapin V. Molecular and metabolic retinoid pathways in the human ocular surface. Mol Vis 2007; 13:1641-1650. [PMID: 17893666].
22. Berezowski P, Strzalka-Mrozik B, Forminska-Kapuscik M, Mazurek U, Filipek E, Nawrocka L, Pieczara E, Banasiak P, Kimsa M. Posttraumatic temporal TGF-ß mRNA expression in lens epithelial cells of paediatric patients. Folia Biol (Praha) 2012; 58:24-29. [PMID: 22464821].
23. Kapral M, Wawszczyk J, Jurzak M, Hollek A, Weglarz L. The effect of inositol hexaphosphate on the expression of selected metalloproteinases and their tissue inhibitors in IL-1β-stimulated colon cancer cells. Int J Colorectal Dis 2012; 27:1419-1428. [PMID: 22415590].
24. Choi BC. Slopes of a receiver operating characteristic curve and likelihood ratios for a diagnostic test. Am J Epidemiol 1998; 148:1127-1132. [PMID: 9850136].
25. Ying GS, Maguire M, Quinn G, Kulp MT, Cyert L. ROC analysis of the accuracy of Noncycloplegic retinoscopy, Retinomax Autorefractor, and SureSight Vision Screener for preschool vision screening. Invest Ophthalmol Vis Sci 2011; 52:9658-9664. [PMID: 22125281].
26. Stafiej J, Malukiewicz G, Lesiewska-Junk H, Rość D, Kaźmierczak K. Endothelial cell markers in patients with pseudoexfoliation syndrome. ScientificWorldJournal 2012; 2012:863949- [PMID: 22593709].
27. Gartaganis SP, Patsoukis NE, Nikolopoulos DK, Georgiou CD. Evidence for oxidative stress in lens epithelial cells in pseudoexfoliation syndrome. Eye (Lond) 2007; 21:1406-1411. [PMID: 17001325].
28. Abu-Amero KK, Kondkar AA, Mousa A, Osman EA, Al-Obeidan SA. Decreased total antioxidants status in the plasma of patients with pseudoexfoliation glaucoma. Mol Vis 2011; 17:2769-2775. [PMID: 22065931].
29. Cumurcu T, Gunduz A, Ozyurt H, Nurcin H, Atis O, Egri M. Increased oxidative stress in patients with pseudoexfoliation syndrome. Ophthalmic Res 2010; 43:169-172. [PMID: 20068368].
30. Engin KN, Yemişci B, Yiǧit U, Aǧaçhan A, Coşkun C. Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients. Mol Vis 2010; 16:1260-1271. [PMID: 20664701].
31. Gherghel D, Griffiths HR, Hilton EJ, Cunliffe IA, Hosking SL. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2005; 46:877-883. [PMID: 15728543].
32. Marchitti SA, Chen Y, Thompson DC, Vasiliou V. Ultraviolet radiation: cellular antioxidant response and the role of ocular aldehyde dehydrogenase enzymes. Eye Contact Lens 2011; 37:206-213. [PMID: 21670692].
33. Lassen N, Black WJ, Estey T, Vasiliou V. The role of corneal crystallins in the cellular defense mechanisms against oxidative stress. Semin Cell Dev Biol 2008; 19:100-112. [PMID: 18077195].
34. Babizhayev MA. Biomarkers and special features of oxidative stress in the anterior segment of the eye linked to lens cataract and the trabecular meshwork injury in primary open-angle glaucoma: challenges of dual combination therapy with N-acetylcarnosine lubricant eye drops and oral formulation of nonhydrolyzed carnosine. Fundam Clin Pharmacol 2012; 26:86-117. [PMID: 21883446].
35. Koliakos GG, Befani CD, Mikropoulos D, Ziakas NG, Konstas AG. Prooxidant-antioxidant balance, peroxide and catalase activity in the aqueous humour and serum of patients with exfoliation syndrome or exfoliative glaucoma. Graefes Arch Clin Exp Ophthalmol 2008; 246:1477-1483. [PMID: 18607617].
36. Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Hollo G, Katsimbris IE, Georgiadis N, Ritch R. 8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol 2003; 87:353-356. [PMID: 12598453].
37. Sorkhabi R, Ghorbanihaghjo A, Javadzadeh A, Rashtchizadeh N, Moharrery M. Oxidative DNA damage and total antioxidant status in glaucoma patients. Mol Vis 2011; 17:41-46. [PMID: 21245957].
38. Yimaz A, Adigüzel U, Tamer L, Yildirim O, Oz O, Vatansever H, Ercan B, Deǧirmenci US, Atik U. Serum oxidant/antioxidant balance in exfoliation syndrome. Clin Experiment Ophthalmol 2005; 33:63-66. [PMID: 15670081].
39. Zoric L, Miric D, Milenkovic S, Jovanovic P, Trajkovic G. Pseudoexfoliation syndrome and its antioxidative protection deficiency as risk factors for age-related cataract. Eur J Ophthalmol 2006; 16:268-273. [PMID: 16703545].
40. Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, Bufidis T, Georgiadis N, Ringvold A. Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol 2002; 134:879-883. [PMID: 12470757].
41. Yaǧci R, Ersöz I, Erdurmuş M, Gürel A, Duman S. Protein carbonyl levels in the aqueous humour and serum of patients with pseudoexfoliation syndrome. Eye (Lond) 2008; 22:128-131. [PMID: 17293783].
42. Yaǧci R, Gürel A, Ersöz I, Keskin UC, Hepşen IF, Duman S, Yiǧitoǧlu R. Oxidative stress and protein oxidation in pseudoexfoliation syndrome. Curr Eye Res 2006; 31:1029-1032. [PMID: 17169841].
43. Diehn JJ, Diehn M, Marmor MF, Brown PO. Differential gene expression in anatomical compartments of the human eye. Genome Biol 2005; 6:R74- [PMID: 16168081].
44. Lee RK. The molecular pathophysiology of pseudoexfoliation glaucoma. Curr Opin Ophthalmol 2008; 19:95-101. [PMID: 18301281].
45. Zenkel M, Kruse FE, Naumann GO, Schlötzer-Schrehardt U. Impaired cytoprotective mechanisms in eyes with pseudoexfoliation syndrome/glaucoma. Invest Ophthalmol Vis Sci 2007; 48:5558-5566. [PMID: 18055805].
46. Reddy VN, Kasahara E, Hiraoka M, Lin LR, Ho YS. Effects of variation in superoxide dismutases (SOD) on oxidative stress and apoptosis in lens epithelium. Exp Eye Res 2004; 79:859-868. [PMID: 15642323].
47. Hirose K, Longo DL, Oppenheim JJ, Matsushima K. Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation. FASEB J 1993; 7:361-368. [PMID: 8440412].
48. Visner GA, Dougall WC, Wilson JM, Burr IA, Nick HS. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. J Biol Chem 1990; 265:2856-2864. [PMID: 2406241].
49. Uçakhan OO, Karel F, Kanpolat A, Devrim E, Durak I. Superoxide dismutase activity in the lens capsule of patients with pseudoexfoliation syndrome and cataract. J Cataract Refract Surg 2006; 32:618-622. [PMID: 16698483].
50. Lin D, Barnett M, Grauer L, Robben J, Jewell A, Takemoto L, Takemoto DJ. Expression of superoxide dismutase in whole lens prevents cataract formation. Mol Vis 2005; 11:853-858. [PMID: 16254550].
51. Johansson K, Järvliden J, Gogvadze V, Morgenstern R. Multiple roles of microsomal glutathione transferase 1 in cellular protection: a mechanistic study. Free Radic Biol Med 2010; 49:1638-1645. [PMID: 20727966].
52. Yildirim Z, Uçgun NI, Kiliç N, Gürsel E, Sepici-Dinçel A. Pseudoexfoliation syndrome and trace elements. Ann N Y Acad Sci 2007; 1100:207-212. [PMID: 17460180].
53. Yilmaz A, Ayaz L, Tamer L. Selenium and pseudoexfoliation syndrome. Am J Ophthalmol 2011; 151:272-276. [PMID: 21168825].
54. Gartaganis SP, Georgakopoulos CD, Patsoukis NE, Gotsis SS, Gartaganis VS, Georgiou CD. Glutathione and lipid peroxide changes in pseudoexfoliation syndrome. Curr Eye Res 2005; 30:647-651. [PMID: 16109644].
55. Chen Y, Koppaka V, Thompson DC, Vasiliou V. Focus on molecules: ALDH1A1: from lens and corneal crystallin to stem cell marker. Exp Eye Res 2012; 102:105-106. [PMID: 21536030].
56. Choudhary S, Xiao T, Vergara LA, Srivastava S, Nees D, Piatigorsky J, Ansari NH. Role of aldehyde dehydrogenase isozymes in the defense of rat lens and human lens epithelial cells against oxidative stress. Invest Ophthalmol Vis Sci 2005; 46:259-267. [PMID: 15623782].
57. King G, Holmes R. Human ocular aldehyde dehydrogenase isozymes: distribution and properties as major soluble proteins in cornea and lens. J Exp Zool 1998; 282:12-17. [PMID: 9723161].
58. Lassen N, Bateman JB, Estey T, Kuszak JR, Nees DW, Piatigorsky J, Duester G, Day BJ, Huang J, Hines LM, Vasiliou V. Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice. J Biol Chem 2007; 282:25668-25676. [PMID: 17567582].
59. Duester G. Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 2000; 267:4315-4324. [PMID: 10880953].
60. Marchitti SA, Brocker C, Stagos D, Vasiliou V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol 2008; 4:697-720. [PMID: 18611112].